Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer

Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer

Breast cancer (BC) encompasses heterogeneous pathologies with different subtypes exhibiting distinct molecular changes, including those related to DNA methylation. However, the role of these changes in mediating BC heterogeneity is poorly understood. Lowly methylated regions (LMRs), non-CpG island l...

Full description

Bibliographic Details
Main Authors: Nora Fernandez-Jimenez, Athena Sklias, Szilvia Ecsedi, Vincent Cahais, Davide Degli-Esposti, Antonin Jay, Pierre Benoit Ancey, Hae Dong Woo, Hector Hernandez-Vargas, Zdenko Herceg
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:Epigenetics
Subjects:
breast cancer subtypes
dna methylome
ebf1
lowly methylated regions
transcription factor binding sites
Online Access:http://dx.doi.org/10.1080/15592294.2017.1373919

Internet

http://dx.doi.org/10.1080/15592294.2017.1373919

Similar Items